129 related articles for article (PubMed ID: 33352323)
1. Recombinant tissue plasminogen activator treatment for COVID-19 associated ARDS and acute cor pulmonale.
Kosanovic D; Yaroshetskiy AI; Tsareva NA; Merzhoeva ZM; Trushenko NV; Nekludova GV; Schermuly RT; Avdeev SN
Int J Infect Dis; 2021 Mar; 104():108-110. PubMed ID: 33352323
[TBL] [Abstract][Full Text] [Related]
2. Salvage use of tissue plasminogen activator (tPA) in the setting of acute respiratory distress syndrome (ARDS) due to COVID-19 in the USA: a Markov decision analysis.
Choudhury R; Barrett CD; Moore HB; Moore EE; McIntyre RC; Moore PK; Talmor DS; Nydam TL; Yaffe MB
World J Emerg Surg; 2020 Apr; 15(1):29. PubMed ID: 32312290
[TBL] [Abstract][Full Text] [Related]
3. Successful use of tPA for thrombolysis in COVID related ARDS: a case series.
Goyal A; Saigal S; Niwariya Y; Sharma J; Singh P
J Thromb Thrombolysis; 2021 Feb; 51(2):293-296. PubMed ID: 32617806
[TBL] [Abstract][Full Text] [Related]
4. Fibrinolytic therapy in patients with COVID-19 and acute respiratory distress syndrome: Is this a feasible approach?
Savioli F; Rocha L; Góis A; Nakano LC
J Trauma Acute Care Surg; 2020 Dec; 89(6):e187-e188. PubMed ID: 32868539
[No Abstract] [Full Text] [Related]
5. Severe COVID-19 with acute respiratory distress syndrome (ARDS) in a sickle cell disease adult patient: case report.
Teulier M; Elabbadi A; Gerotziafas G; Lionnet F; Voiriot G; Fartoukh M
BMC Pulm Med; 2021 Jan; 21(1):46. PubMed ID: 33514354
[TBL] [Abstract][Full Text] [Related]
6. A Case Report for Using Methylprednisolone for Severe ARDS Caused by SARS-CoV-2 Delta Variant in a Pediatric Patient With Lennox-Gastaut Syndrome.
Park E; You J
J Korean Med Sci; 2022 Mar; 37(10):e82. PubMed ID: 35289141
[TBL] [Abstract][Full Text] [Related]
7. Rapid resolution of acute cor pulmonale with recombinant tissue plasminogen activator.
Gore JM; Thompson MJ; Becker RC
Chest; 1989 Oct; 96(4):939-41. PubMed ID: 2507233
[TBL] [Abstract][Full Text] [Related]
8. Systemic fibrinolysis for acute pulmonary embolism complicating acute respiratory distress syndrome in severe COVID-19: a case series.
Della Bona R; Valbusa A; La Malfa G; Giacobbe DR; Ameri P; Patroniti N; Robba C; Gilad V; Insorsi A; Bassetti M; Pelosi P; Porto I;
Eur Heart J Cardiovasc Pharmacother; 2021 Jan; 7(1):78-80. PubMed ID: 32663257
[No Abstract] [Full Text] [Related]
9. Efficacy and Safety of Thrombolysis in COVID-19 Related ARDS.
Goyal A; Niwariya Y; Pawar N; Khurana A; Chaudhary P
Recent Adv Antiinfect Drug Discov; 2023; 18(3):197-204. PubMed ID: 36237163
[TBL] [Abstract][Full Text] [Related]
10. Acute Cor Pulmonale in COVID-19-Related ARDS: Improvement With Almitrine Infusion.
Huette P; Beyls C; Guilbart M; Haye G; Najid FZ; Mestan B; Roger PA; Dupont H; Abou-Arab O; Mahjoub Y
JACC Case Rep; 2020 Jul; 2(9):1311-1314. PubMed ID: 32835274
[TBL] [Abstract][Full Text] [Related]
11. Acute cor pulmonale in patients with acute respiratory distress syndrome due to COVID-19.
Zapata L; Suárez-Montero JC; Flores-Orella MN; Morales-Alarcón EM; Segarra A; Santos-Rodríguez JA
Med Intensiva (Engl Ed); 2022 Nov; 46(11):645-647. PubMed ID: 36088263
[No Abstract] [Full Text] [Related]
12. Life-threatening pulmonary embolism with right-sided heart thrombus. Rapid recovery with recombinant tissue plasminogen activator.
d'Ivernois C; Le Metayer P; Fischer B; Haissaguerre M; Warin JF
Chest; 1994 Apr; 105(4):1291-2. PubMed ID: 8162778
[TBL] [Abstract][Full Text] [Related]
13. Increased physiological dead space in mechanically ventilated COVID-19 patients recovering from severe acute respiratory distress syndrome: a case report.
Xia J; Feng Y; Li M; Yu X; Zhang Y; Duan J; Zhan Q
BMC Infect Dis; 2020 Aug; 20(1):637. PubMed ID: 32854630
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of ruxolitinib for Covid-19 related acute respiratory distress syndrome in a patient with blastic plasmacytoid dendritic cell neoplasm (leukemic variant).
Sammartano V; Santoni A; Frediani B; Sicuranza A; Emanuele C; Franchi F; Capochiani E; Bocchia M
Leuk Lymphoma; 2020 Dec; 61(14):3523-3525. PubMed ID: 32902339
[No Abstract] [Full Text] [Related]
15. Severe Acute Cor Pulmonale in Patients with COVID-19 Acute Respiratory Distress Syndrome: Caution with Left Turn.
Evrard B; Goudelin M; Vaidie J; Fedou AL; Vignon P
Am J Respir Crit Care Med; 2022 Apr; 205(8):961-964. PubMed ID: 35120295
[No Abstract] [Full Text] [Related]
16. High lipasemia is frequent in Covid-19 associated acute respiratory distress syndrome.
Rasch S; Herner A; Schmid RM; Huber W; Lahmer T
Pancreatology; 2021 Jan; 21(1):306-311. PubMed ID: 33277183
[TBL] [Abstract][Full Text] [Related]
17. Acute cor pulmonale from saddle pulmonary embolism in a patient with previous COVID-19: should we prolong prophylactic anticoagulation?
Ali S; Mathew S; Pappachan JM
Int J Infect Dis; 2020 Aug; 97():299-302. PubMed ID: 32544670
[TBL] [Abstract][Full Text] [Related]
18. Using the lung ultrasound score to monitor disease progression for COVID-19-associated ARDS.
Nguyen M; Gaujard G; Guinot PG; Bouhemad B;
Intensive Care Med; 2021 Nov; 47(11):1329-1331. PubMed ID: 34595567
[No Abstract] [Full Text] [Related]
19. Rescue therapy for severe COVID-19-associated acute respiratory distress syndrome with tissue plasminogen activator: A case series.
Barrett CD; Oren-Grinberg A; Chao E; Moraco AH; Martin MJ; Reddy SH; Ilg AM; Jhunjhunwala R; Uribe M; Moore HB; Moore EE; Baedorf-Kassis EN; Krajewski ML; Talmor DS; Shaefi S; Yaffe MB
J Trauma Acute Care Surg; 2020 Sep; 89(3):453-457. PubMed ID: 32427773
[TBL] [Abstract][Full Text] [Related]
20. Myasthenia gravis at the crossroad of COVID-19: focus on immunological and respiratory interplay.
Galassi G; Marchioni A
Acta Neurol Belg; 2021 Jun; 121(3):633-642. PubMed ID: 33811309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
